NEURO TOUCH stands at the forefront of Quantitative Sensory Testing (QST) technology, incorporating biothesiometer capabilities to deliver unmatched precision in assessing sensory nerve functions. This advanced system provides highly sensitive and validated evaluations, designed to non-invasively gauge nerve responses to specific stimuli, including those measured by a biothesiometer. NEURO TOUCH offers a seamless and gentle assessment experience, establishing a new benchmark in neuropathy assessments with its integrated biothesiometer features.

Refining the approach to neuropathy diagnosis, NEURO TOUCH quantifies sensory nerve function, which is essential for detecting early, pre-clinical nerve damage as well as small or mixed-fiber neuropathies. As a comprehensive diagnostic tool, NEURO TOUCH provides a thorough overview of nerve health, including its biothesiometer functionality. This enables timely and effective interventions to prevent severe outcomes in patients, particularly those with diabetic neuropathy.

Empowering healthcare professionals, NEURO TOUCH supports standardized QST evaluations using cutting-edge technology, including biothesiometer assessments. This feature is critical for detecting early signs of diabetic peripheral neuropathy (DPN), thereby reducing the risk of severe complications such as foot ulcers and amputations. With NEURO TOUCH, practitioners can rely on the advanced Biothesiometer (Vibration Perception Test), Digital Monofilament, and Hot & Cold Perception Tests to guide their clinical decisions, ensuring optimal patient care and preventive strategies.